Garde Capital’s Colgate-Palmolive CL Stock Holding History

Garde Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,553	Closed	-$141K	–	353
2025 Q2	$141K	Hold	1,553	–	–	0.01%	250
2025 Q1	$146K	Hold	1,553	–	–	0.01%	239
2024 Q4	$141K	Hold	1,553	–	–	0.01%	242
2024 Q3	$161K	Buy	1,553 +253	+19%	+$25.8K	0.01%	222
2024 Q2	$126K	Hold	1,300	–	–	0.01%	242
2024 Q1	$117K	Hold	1,300	–	–	0.01%	265
2023 Q4	$104K	Buy	+1,300	New	+$97.7K	0.01%	275
2023 Q3	–	Sell	-1,300	Closed	-$100K	–	259
2023 Q2	$100K	Buy	+1,300	New	+$101K	0.01%	280
2023 Q1	–	Sell	-1,300	Closed	-$102K	–	257
2022 Q4	$102K	Buy	+1,300	New	+$97.5K	0.01%	247
2022 Q3	–	Sell	-1,300	Closed	-$104K	–	243
2022 Q2	$104K	Buy	+1,300	New	+$102K	0.01%	259
2022 Q1	–	Sell	-1,300	Closed	-$111K	–	277
2021 Q4	$111K	Buy	+1,300	New	+$102K	0.01%	276
2021 Q3	–	Sell	-1,300	Closed	-$106K	–	279
2021 Q2	$106K	Sell	1,300 -150	-10%	-$12.3K	0.01%	265
2021 Q1	$114K	Hold	1,450	–	–	0.01%	239
2020 Q4	$123K	Buy	+1,450	New	+$120K	0.02%	227

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Garde Capital's CL Position: Q3 2025 in Review

Garde Capital sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 1,553 shares — an estimated $141K sold.

Garde Capital first reported a position in CL in Q4 2020 and held it in 14 quarters. The position peaked at $161K in Q3 2024. 1,847 funds tracked by Wall St. Rank hold CL as of Q3 2025.

Garde Capital reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
Garde Capital sold 1,553 Colgate-Palmolive shares in Q3 2025, an estimated $141K.
Garde Capital first reported a position in Colgate-Palmolive in Q4 2020 and held it in 14 quarters.
Garde Capital's Colgate-Palmolive position peaked at $161K in Q3 2024.
1,847 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.